CFMG & Wellpath in California — a documentary investigation · Article 011 of 100 · Series 2 — Inside the management agreement

What the MSA Actually Reserves to Physicians

Published

20 September 2026, 6:00 PM PT

Content last changed

25 September 2026

Public-evidence cutoff

25 September 2026

Sources checked

25 September 2026

Record through

25 September 2026

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

What the MSA Actually Reserves to Physicians turns on the difference between authority written on paper and authority demonstrated in operation. The analysis reads the management-services architecture as a division of functions, then tests whether the economic and administrative structure supports, constrains, or leaves unanswered the professional authority formally reserved to CFMG.

The governing question is narrow: Which professional functions are expressly left with CFMG, and why are those clauses important contrary evidence? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

Employment-control cluster#

Overfield — one of the strongest public physician-employment cases. The record treats the physician as a CFMG employee while enterprise-associated HR personnel supply corporate testimony concerning termination. The current public record does not establish that the termination arose from clinical judgment; contrary testimony matters.

Vizgaudis-Gomez — separate CFMG/Wellpath defendants in an employment setting; high potential but do not infer joint employment before the Mendoza declaration and merits record are reviewed.

Wagner and related Nevada County records — useful for workforce and program allocation rather than automatic CPOM conclusions.

Enterprise quality system#

The reviewed public litigation establishes a substantive enterprise clinical-quality system, including:

• Clinical Mortality Review;

• Administrative Mortality Review;

• Part III / Form 01c;

• local RHA/HSA drafting;

• Wellpath Corporate Office receipt;

• Patient Safety Committee;

• CQI / Quality Innovations;

• PSES;

• external PSO reporting;

• County/client participation;

• root-cause analysis;

• improvement planning.

This defeats the early simplistic model “CFMG = clinical, Wellpath = only administrative.”

II. Structural and Historical Context#

What the timeline does not answer#

The corporate history tells us who appeared where.

It does not yet answer:

• who owned CFMG shares during every period;

• what rights were contained in the CFMG-specific stock-transfer restriction agreements;

• whether CFMG could replace Wellpath as manager without significant contractual consequences;

• how formal physician authority operated in practice;

• or which entity had the last word in a disputed physician-reserved decision.

Those are subjects for the management-architecture, litigation and authority-map pages.

III. The Control and Governance Analysis#

Why California law makes that distinction important#

The Medical Board of California says the state’s corporate-practice doctrine is intended to prevent unlicensed persons from interfering with physician professional judgment. Its current guidance identifies decisions such as diagnostic testing, referrals, ultimate patient care, physician workload and hours, clinically related hiring or firing, medical-record control, coding and billing, and medical-equipment decisions as areas in which physician authority matters. The Board says an MSO may be consulted, but the licensed physician must retain ultimate responsibility or approval for decisions that cannot be delegated. Source: Medical Board of California

That does not mean a large MSO is inherently unlawful.

It means the boundary matters .

What the Medical Board says physicians must control#

The Medical Board of California’s current corporate-practice guidance makes the line unusually concrete.

The Board says the doctrine is intended to prevent unlicensed persons from interfering with or influencing professional judgment. It identifies several healthcare decisions that should be made by California-licensed physicians:

• appropriate diagnostic testing;

• referrals and specialist consultation;

• responsibility for the patient’s ultimate overall care and treatment options;

• how many patients a physician must see;

• how many hours a physician must work.

The Board then identifies additional “business” or “management” decisions that can amount to control of medical practice, including:

• control of medical records and their contents;

• physician and clinical-staff hiring or firing when clinical competency or proficiency is involved;

• parameters for payer relationships;

• coding and billing procedures;

• selection of medical equipment and supplies.

Medical Board of California — Practice Information

That list is crucial because it prevents two analytical mistakes.

The “last word” test#

The Medical Board’s guidance says that while physicians may consult unlicensed persons regarding relevant management decisions, the physician must retain ultimate responsibility or approval for the decisions that cannot be delegated.

That gives this investigation a practical test.

For any disputed function, ask:

• Who identified the issue?

• Who gathered the information?

• Who made the recommendation?

• Did a licensed physician independently review it?

• Who had authority to approve, reject or modify the recommendation?

• Who implemented the result?

• What happened when management and physician leadership disagreed?

The identity of the person who sends the email or changes the computer status may not answer the question.

The legally important actor may be the person who possessed the final veto.

Why physician workload belongs in the analysis#

One of the most significant parts of the Medical Board’s guidance is its express treatment of workload.

The Board lists both:

• how many patients a physician must see; and

• how many hours a physician must work

as physician decisions.

That matters in correctional healthcare because staffing, census, contractual service levels and custody operations can all influence workload.

An investigation therefore has to distinguish among:

• a County’s contractual staffing requirement;

• an MSO’s workforce recommendation;

• a professional corporation’s physician-staffing decision;

• and an individual physician’s patient-specific clinical judgment.

Those are different sources of authority.

Layer three: the Company Designee#

One of the most important governance provisions appears early in the agreement.

When the contract calls for CFMG approval, consent, direction or other action — unless the agreement says otherwise — action by the person designated as CFMG’s chief executive officer under its bylaws, termed the Company Designee , can constitute action by CFMG.

The agreement also provides for a management-company representative to attend and participate in certain meetings involving the Company Designee and equityholders, in a non-voting capacity.

This is a governance-adjacent mechanism.

It proves that the management relationship reached beyond isolated back-office tasks.

It does not prove that the manager had a vote or could compel a professional decision.

The public investigation therefore needs to identify:

• who served as Company Designee over time;

• what authority CFMG’s bylaws gave that role;

• and what categories of decisions moved through that approval channel.

Layer five: professional functions assigned to CFMG#

Section 3.4 assigns CFMG responsibility, in consultation with the manager, for several functions near the heart of professional governance.

These include:

• utilization review and quality-assurance guidelines;

• physician documentation;

• physician corrective action;

• credentialing physicians for specific procedures;

• handling impaired physicians;

• and policies of a purely medical nature.

The contract therefore does not simply say “CFMG handles medicine” in general terms.

It identifies particular areas where CFMG is supposed to remain responsible.

For the public investigation, those categories become testable domains.

Layer six: physicians are employed or engaged by CFMG — but management shapes the employment architecture#

The agreement says CFMG employs or engages the physicians necessary for the practice.

That is formal evidence of CFMG’s employer role.

But the employment architecture is shared.

The agreement provides that forms of physician employment agreements are prepared through the management organization and approved by CFMG. It further states that CFMG may not amend the form without the manager’s prior written approval.

The manager also provides extensive physician HR support, including categories such as:

• employment policies and forms;

• background-check support;

• orientation;

• benefits administration;

• workers’ compensation and EEO-related administration;

• software education;

• physician database maintenance.

This is a particularly useful example of why “who is the employer?” and “who administers employment?” are not always the same question.

The public contract places CFMG in the physician-employer position while giving the manager a major role in the employment infrastructure.

Layer seven: finance and cash management#

The agreement also creates substantial financial integration.

The management-services package includes:

• accounting;

• financial reporting;

• invoicing;

• payroll/tax support;

• budgeting;

• cash management;

• benefit and bonus-plan administration.

Exhibit D provides for a management fee calculated as a percentage of adjusted gross revenues — identified in the filed version as 18% — and states that the parties regarded the fee as fair-market-value compensation for management services.

The same exhibit authorizes specified disbursement mechanics and grants the management company a security interest in CFMG assets to the extent permitted by law, with references to broader credit arrangements.

These are economically important provisions.

They are not, by themselves, proof of professional control.

But they make separate questions worth investigating:

• How economically dependent was CFMG on the management structure?

• What happened if the management agreement ended?

• What did the referenced deficit-funding and credit documents provide?

• Could financial remedies affect the practical ability to change managers?

Those questions require the related contracts, not inference from the MSA alone.

It does not prove#

• that every formal safeguard was followed in practice;

• that the management company actually overrode CFMG physicians;

• that CFMG exercised an independent veto in every relevant event;

• that Wellpath owned CFMG professional-corporation shares;

• what the stock-transfer restrictions actually provided;

• or that the structure violated California law.

Those conclusions require evidence beyond the contract.

Current contract continuity#

Fresno's formal jail-health agreement continues in CFMG's name through major amendments. Amendment XII, approved December 3, 2024, extended the agreement through June 30, 2029 with optional years. Amendment XIII (County File 26-0855) adds CalAIM Justice-Involved prerelease services and raises the cumulative ceiling by $6,104,438 to $400,479,492. The post–September 22, 2026 County record assigns it Agreement No. 26-459 and Resolution No. 26-329 and lists a Digital Signature Certificate among the filed materials. The Legistar page's “Final action” field remains blank, so this investigation does not characterize Board approval as conclusively recorded from that page alone.

This is powerful current evidence of CFMG juridical continuity after bankruptcy and after creation of Local Government–California.

The same County record also separates the layers. The formal counterparty is California Forensic Medical Group, Incorporated, but the County's discussion says Wellpath will provide and coordinate the CalAIM services, ensure that its staff are credentialed to bill Medi-Cal and trained for billable documentation, and use Medusind, Inc. as its subcontracted billing vendor. That supports an operating-layer reading of Wellpath; it does not establish ownership of CFMG, clinical control, or the employer of any particular worker. See Article 031.

Sonoma — clearest current PC/MSO recital#

Sonoma's 2026 MAT agreement is among the strongest current documents because it names CFMG as contractor and separately identifies Wellpath LLC as the Management Services Organization providing functions such as accounting, regulatory support, claims/litigation assistance, payroll, invoicing, risk management, and HR. The same contract separately gives the County powers over staffing, audits, security, and removal of assigned personnel.

This is a clean example of distributed authority , not one actor controlling everything.

Program allocation is itself a control question#

Across counties, JBCT and related services appear under different entities. This raises questions about who decides:

• which PC carries a program;

• which entity employs staff;

• how workers transfer when a program moves;

• which PC holds clinical responsibility;

• whether enterprise economics or professional governance drives the allocation.

No general conclusion should be drawn without program-specific contracts.

Master reader orientation#

The final project conclusion is not that CFMG and Wellpath are “the same entity,” nor that they are operational strangers.

The record supports a layered model:

• CFMG — legally distinct California professional corporation; formal County contractor and strong formal physician-employer evidence; claimed physician-governance authority.

• Wellpath / management entities — extensive MSO/enterprise infrastructure across HR, systems, compensation, credentialing administration, finance, claims, records, litigation, and other operational domains.

• County/client authority — an independent source of contract, security, access, transportation, remedial-plan, and operational requirements.

• Individual licensed clinicians — patient-specific professional judgment and other physician-reserved functions.

The final unresolved issue is function-specific:

When an administrative process reached a decision California reserves to physicians, who possessed practical final approval or veto, and what happened when CFMG and Wellpath disagreed?

December 31, 2012 Management Services Agreement#

An executed Management Services Agreement dated December 31, 2012 is the most important structural document identified so far.

The agreement contains substantial language favoring legality:

• CFMG and the management company are described as separate independent entities.

• CFMG formally employs or engages physicians.

• Professional medical services and medical judgment are reserved to CFMG.

• The management company is prohibited from itself practicing medicine or directly assuming patient-care responsibility.

• The relationship is framed as administrative support rather than professional control.

Those provisions must be given genuine weight.

At the same time, the agreement creates a deeply integrated administrative relationship. The management company is made CFMG's exclusive management-services provider and receives broad responsibilities involving:

• accounting and financial administration;

• payroll and tax functions;

• employee and physician benefit administration;

• physician-employment documentation and policy administration;

• human-resources support;

• staffing analysis;

• physician compensation administration and recommendations;

• billing and coding support;

• information technology;

• electronic health-record systems and operational records;

• county/client contracting support;

• compliance and licensing support;

• insurance and risk-management functions;

• litigation support;

• purchasing and equipment administration;

• banking and budgeting;

• participation in governance-related processes.

This combination—formal reservation of physician authority plus extensive management-company operational authority—is the structural issue that must be tested against actual conduct.

Domain ten — quality assurance, mortality review, and corrective action#

This domain supplies some of the strongest evidence favoring a genuine CFMG professional function.

The MSA assigns CFMG responsibility, in consultation with management, for utilization-review guidelines, quality-assurance guidelines, physician corrective action, impaired physicians, and pure-medical policies.

In Estate of Tomi Kartchner , CFMG asserted quality/patient-safety protection over a Mortality and Morbidity Review Report. The court ultimately compelled disputed material because CFMG had not established the claimed privilege for that report on the record before it.

The important structural point is not the privilege loss. It is that CFMG asserted a role associated with a clinical mortality/quality-review process.

That is potentially strong contrary evidence to any theory that CFMG performs no substantive professional governance.

Still unknown:

• who selected committee members;

• who employed them;

• who chaired and voted;

• whether Wellpath quality leadership participated;

• who approved findings;

• who imposed corrective action;

• whether CFMG physicians had the final medical determination.

Override Test: Find a mortality/quality recommendation opposed by operations or finance and identify whose position prevailed.

STRONGEST EVIDENCE FAVORING A LAWFUL CFMG–MSO STRUCTURE#

An attorney-grade analysis must state the strongest defense evidence clearly:

• The MSA expressly reserves physician professional judgment.

• Any MSO act constituting medical practice is contractually declared void.

• CFMG has final contractual responsibility for physician staffing levels.

• CFMG is assigned responsibility for utilization review, QA, corrective action, credentialing, impaired physicians, and pure-medical policies.

• CFMG is treated as the HIPAA covered entity and the manager as business associate.

• CFMG continued as a real legal entity through and after Wellpath bankruptcy.

• CFMG continued contracting directly with California counties.

• Heather Hole testified that CFMG employees are paid by CFMG and she would not consider them Wellpath employees.

• Chapman testified his termination, as he understood it, was unrelated to treatment decisions.

• CFMG asserted a clinical quality-review privilege in Kartchner .

• Senior Wellpath leadership contemporaneously represented communications were occurring with CFMG leadership’s knowledge and approval.

• No identified court has held the entire CFMG–Wellpath structure unlawful under section 2400.

These are substantial facts and should not be dismissed as technicalities.

Cfmg's termination rights are real, but narrowly structured#

Section 5.2 permits CFMG to terminate immediately if the management company materially breaches the MSA, fails to cure within 45 days after written notice, and the breach materially adversely affects CFMG.

The required notice must be executed by the Company Designee to be effective.

CFMG can also terminate if the management company enters specified insolvency proceedings.

This is meaningful termination authority.

It is evidence against an assertion that CFMG had literally no contractual exit right.

But several structural features narrow that freedom.

First, the agreement does not appear to provide CFMG a broad termination-for-convenience right during the term.

Second, CFMG's breach notice must come from the Company Designee.

Third, the management company has its own termination rights.

Fourth, termination of the Deficit Funding Loan Agreement gives the management company an immediate termination right under the MSA.

Fifth, certain breaches can trigger substantial payment consequences.

Accordingly, the proper question is not whether CFMG had some termination right.

It is:

Could the physician corporation realistically choose a new MSO simply because its physicians preferred a different manager?

On the current text, that proposition is not established.

The 2012 MSA baseline — the structure was designed to split employment functions#

The employment ambiguity is not accidental when viewed against the management agreement architecture developed earlier in this series.

The 2012 Management Services Agreement assigns the professional corporation the physician-practice role while giving the management organization broad administrative responsibilities.

the record attributes to CFMG the formal responsibility to employ or engage physicians and preserve professional medical judgment.

The management side, by contrast, was assigned extensive nonclinical infrastructure, including functions such as:

• accounting;

• payroll and tax administration;

• benefits administration;

• physician-employment documentation and policies;

• human-resources support;

• staffing analysis;

• compensation administration and recommendations;

• billing;

• information technology;

• electronic-record infrastructure;

• insurance/risk;

• litigation support;

• budgeting;

• banking;

• purchasing;

• compliance;

• and contract support.

This is precisely the kind of arrangement in which the same physician can truthfully encounter:

• a CFMG employer name on a tax record;

• a Wellpath HR representative;

• a Wellpath payroll system;

• a Wellpath handbook;

• a Wellpath benefits platform;

• a Wellpath-branded credentialing intake;

• and contemporaneous professional-employment decision records — not located in the public record for this project.

The presence of both names is therefore not, standing alone, proof of fraud, alter ego, or unlawful practice.

The investigative question is whether the division actually stayed within lawful boundaries .

The 2012 management-agreement baseline#

Earlier articles in this series identified the December 31, 2012 Management Services Agreement as the central structural instrument in the modern CFMG–MSO arrangement.

The reviewed project record attributes to that agreement several provisions favoring a lawful PC–MSO architecture:

• CFMG and the management organization are described as separate entities;

• CFMG formally employs or engages physicians;

• professional medical services and medical judgment are reserved to CFMG;

• the management organization is not itself to practice medicine or assume direct patient-care responsibility;

• broad administrative services are delegated to the management side.

The same record describes the management organization as having extensive responsibilities concerning:

• payroll and benefits administration;

• physician-employment documentation;

• HR support;

• staffing analysis;

• compensation administration and recommendations;

• billing and coding support;

• IT and electronic-record systems;

• insurance and risk;

• litigation support;

• contracting;

• purchasing and equipment;

• finance, banking, and budgeting;

• and participation in governance-related processes.

A project submission that reviewed the executed agreement also identifies a potentially important “Company Designee” mechanism, under which certain CFMG actions or approvals may be communicated through a designated CFMG officer or designee and relied upon by the management organization as CFMG action.

That mechanism is not inherently improper. But it makes authentication of the approval chain essential. If CFMG decisions were routinely transmitted through one designee, the investigation must know:

• who held that role at each relevant time;

• whether the designee was a licensed physician;

• what authority had been delegated;

• whether professional decisions could be delegated at all;

• what record showed the underlying physician decision;

• and whether the MSO could act without obtaining a fresh CFMG approval.

The MSA therefore provides the formal hypothesis. the prior analysis tests whether actual conduct matched it.

Evidentiary caution: the standalone executed 2012 MSA has not yet been separately indexed in the current saved Library under an obvious filename. the investigation's existing section-by-section crosswalk should be treated as a strong retrieval guide, while the executed agreement, exhibits, assignments, amendments, and designee records remain Tier-One authentication targets.

Why an override census is more probative than a control narrative#

The phrase “who controlled CFMG?” is too broad to be useful without identifying the function, time, site, and decision.

A professional corporation can lawfully delegate or outsource administrative implementation while retaining protected professional authority. A management organization can also influence outcomes without formally owning the professional decision. The only reliable way to distinguish the two is to reconstruct concrete events.

For each event the record now asks:

• What triggered the decision?

• Who opened the workflow?

• Who developed the factual record?

• Who recommended an outcome?

• Was a professional review required?

• Which licensed physician or physician body performed that review?

• Could that reviewer reject the recommendation?

• Did the reviewer ever ask questions, delay action, impose conditions, modify reasoning, dissent, or say no?

• Who entered the final decision into the operational system?

• Did implementation occur before or after professional approval?

• What happened when the professional and administrative participants disagreed?

The last question is the most valuable.

If Wellpath recommends termination and a CFMG physician body rejects termination, and the physician remains employed, the event strongly supports practical CFMG veto power. If Wellpath proposes a workload target and a CFMG medical director reduces it for safety reasons, and the reduced target governs despite financial cost, that is strong evidence of professional independence. If a Wellpath utilization mechanism initially denies an outside referral and a CFMG physician reverses the denial, that can show physician authority over patient-specific care.

The reverse matters too. If a CFMG physician rejects an administrative recommendation but Wellpath proceeds anyway, or if Wellpath implements a clinically sensitive action before any CFMG physician review, that would weigh in the opposite direction.

Routine concurrence has much less discriminatory value. A physician can agree with an MSO recommendation for legitimate reasons. A long series of unanimous decisions proves little unless the record also shows that disagreement was practically possible.

Fresno's strongest evidence that would support practical Wellpath control#

The following would point the other way if established:

• Wellpath operations determine physician patient loads despite CFMG safety objection.

• Wellpath nonphysician administration can finally deny medically necessary referrals.

• Wellpath independently determines a physician is clinically unsafe to return.

• CFMG physician review occurs only after HR/IT action is irreversible.

• Wellpath controls physician privileges rather than credentialing administration only.

• CFMG physician board lacks records, charter, or practical ability to reject recommendations.

• national Wellpath clinical policies bind Fresno without CFMG professional approval.

• Wellpath controls peer-review outcomes.

• CFMG physicians cannot access records needed to exercise supposed authority.

• actual contrary CFMG physician instructions are ignored.

No item should be treated as proved without event-level evidence.

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: The strongest contrary evidence is the MSA's explicit reservation of professional authority and real termination rights. The article must distinguish structural leverage from proof of an actual unlawful medical decision.

Art Center Holdings#

In April 2026, Attorney General Rob Bonta announced an amicus brief in Art Center Holdings, Inc. v. WCE CA Art . The Attorney General’s public statement emphasized that MSOs may provide administrative and back-office support but cannot own or operate medical practices or exercise undue influence over licensed medical professionals. California DOJ — Apr. 1, 2026

The analysis also focuses attention on contractual rights affecting physician ownership and owner replacement.

That is an important legal lens.

It is not a final appellate holding that every similar contractual feature is unlawful, and it is not evidence that CFMG has the same ownership provisions.

What this legal framework does not prove#

Nothing on this page establishes that:

• Wellpath unlawfully practiced medicine;

• CFMG failed to exercise professional independence;

• a particular management function violated §2400;

• a particular shareholder arrangement was unlawful;

• or a regulator or court has adjudicated the CFMG–Wellpath structure unlawful.

Those are factual and legal conclusions that require CFMG-specific evidence.

The purpose of the framework is to identify what evidence would matter.

The most important development from this analysis is not another malpractice case. It is a pattern of formal identity descriptions that change depending on the legal or institutional context .

Across the period reviewed, the relationship has been described in at least the following ways:

• CFMG as the California professional corporation and Wellpath as its management-services organization;

• CFMG “dba Wellpath” in county contracting records;

• CFMG and Wellpath as “for all intents and purposes” the same entity for purposes of particular litigation and discovery;

• Wellpath and CFMG as having effectively the same recordkeeping, employees, and other functions for discovery purposes;

• CFMG as “separate and distinct” from Wellpath after bankruptcy forced the parties to identify the correct non-debtor California entity;

• CFMG as a “subsidiary company of Wellpath Management Inc.” in a post-bankruptcy Tulare stipulation based on advice reportedly received from bankruptcy counsel;

• CFMG as a “corporate parent” of Wellpath LLC in several Northern District of California interested-entity disclosures;

• CFMG as an “other affiliate” of Wellpath in another federal disclosure;

• Wellpath LLC as an “other affiliate” of CFMG in a 2026 disclosure;

• CFMG as the formal employer in NLRB proceedings while unions and public-facing labor communications identify the workforce as Wellpath workers;

• CFMG as the county contractor while Wellpath is expressly identified by counties as the MSO providing payroll, HR, risk, litigation support, accounting, licensing, and related infrastructure.

These descriptions cannot simply be stacked together as proof that one of them is false. Different legal questions legitimately produce different descriptions. A professional corporation may be a separate juridical entity, use a common brand, outsource extensive administrative functions, participate in a consolidated insurance program, and still remain the lawful physician-controlled medical corporation.

What makes this record important is the repeated difficulty of identifying where formal CFMG authority ends and Wellpath authority begins . That difficulty appears not only in plaintiff pleadings, but in government procurement records, labor records, defense stipulations, bankruptcy papers, corporate-disclosure filings, and the companies’ own operating materials.

This article therefore adopts an additional research rule:

Identity labels are evidence of how the relationship was represented, not proof of how authority was actually allocated.

The final CPOM analysis must turn on decision rights and decision practice , not nomenclature.

B. The 2012 MSA is substantial exculpatory evidence#

the investigation-reviewed MSA contains precisely the provisions one would expect in a lawful California PC–MSO architecture:

• separate-entity language;

• professional independence language;

• formal physician employment by CFMG;

• reservation of professional medical judgment;

• prohibitions on the manager practicing medicine;

• broad but defined administrative services.

The defense should insist that these provisions are not "mere paper."

Contracts are evidence of intended and allocated authority.

A regulator cannot infer that every contractual boundary was ignored merely because the MSO performed many administrative functions.

The agreement's use of an exclusive manager is also not inherently unlawful. Large practices often centralize systems and support functions for efficiency. Exclusivity may be commercially important without transferring professional rights.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include Company Designee history, practical MSO replacement, compensation veto, and an actual event where formal professional authority changed management's preferred outcome.

the investigation has now reached the most important unresolved structural issue in the CFMG–Wellpath relationship.

There is strong public evidence that:

• California Forensic Medical Group, Incorporated (“CFMG”) is a California professional corporation.

• Wellpath has repeatedly represented CFMG and its other professional corporations as physician-owned.

• The January 2019 CFMG assignment expressly transferred to Wellpath LLC the CFMG Management Services Agreement together with related instruments, including relevant stock-transfer restriction agreements .

• Wellpath’s November 2024 bankruptcy filing independently confirms that its nationwide “friendly professional corporation” model used Stock Transfer Agreements with certain physician owners.

• Wellpath said those agreements restricted physician share transfers to facilitate ownership succession, regulatory compliance, continuity of care, and continued administrative services by the Wellpath debtors.

• Wellpath further said that, under those Stock Transfer Agreements, the debtors had authority to help ensure that a professional corporation remained licensed and qualified.

• California’s Medical Board has long identified restrictions on a physician’s ability to vote, sell, or transfer professional-corporation shares without a lay corporation’s permission as a possible indicator of unlicensed corporate practice.

• California’s Attorney General in 2026 placed physician-owner replacement rights at the center of its challenge to “captive” or “friendly” professional-corporation arrangements.

• The Carbon Health enforcement matter likewise alleged that an MSO unlawfully controlled physician-owned practices when it could replace the physician owner while the physician could not replace the MSO without risking ownership.

But the single document necessary to determine whether CFMG itself crossed that line has not yet been located:

the CFMG-specific stock-transfer restriction / succession agreement.

The absence of the instrument prevents a responsible conclusion about whether Wellpath possessed:

• nomination rights;

• approval rights;

• veto rights;

• replacement rights;

• stock options;

• proxies;

• powers of attorney;

• automatic transfer rights;

• rights tied to a physician’s employment;

• or rights triggered by termination of the MSA.

Accordingly, this article does not label CFMG a “captive PC.”

Instead, it establishes a provision-by-provision test that can answer the question once the document is found.

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 010 — The 2026 California Stack: CFMG, Wellpath Operations, Enterprise Clinical Leadership, Zenova, and the County

• Article 012 — The Other Half of the MSA: How Broad the Management Grant Really Is

• Article 009 — From Chapter 11 to Local Government–California: The 2026 Reorganization of the Operating Layer

undefined

The reservations against the 2026 standard#

Senate Bill 351, effective 1 January 2026, codifies California’s corporate-practice-of-medicine prohibition, and the Attorney General’s amicus brief of 30 March 2026 in Art Center Holdings , No. B338625, argues that the prohibition reaches a lay entity’s right to control rather than only its exercise. That matters for a reservations clause specifically: on a right-of-control reading, what an agreement reserves to physicians is the operative text, and a reservation that is comprehensive on its face is evidence of compliance in a way that an operating history is not. The California Medical Association’s brief of 13 April 2026 argues the opposite emphasis, urging that powers be assessed on the facts of their use. Neither is law; the appeal is pending. What the split establishes is that the clause examined in this article is the document a contested analysis would start from, and that reading it against the management grant — as this article does — is the right method under either approach.

IX. The reservation clauses must be tested against actual decisions#

The strongest language in the 2012 MSA is the language reserving professional medical services and physician judgment to CFMG. In a corporate-practice analysis, those clauses are not decorative. They define the contractual boundary the parties represented they intended to preserve. The investigative task is to determine whether the boundary functioned when administrative and professional interests diverged.

The staffing provision provides a particularly clean test. The manager may review needs and make recommendations, while final determinations concerning physician staffing are assigned to CFMG. That distinction creates an observable decision chain. A complete record should show who generated the staffing recommendation, what clinical and financial inputs were considered, which CFMG physician or body made the final determination, and whether implementation followed that determination. If the final decision was genuinely made by CFMG even when it increased cost or conflicted with management preference, that is strong evidence that the reservation had practical force.

The same analysis applies to physician selection, professional competence, clinical protocols, referral criteria, peer review, and discipline for professional reasons. Administrative participation is not automatically improper. Recruiting staff can collect applications; HR can coordinate interviews; finance can model compensation; quality teams can collect data. The critical question is whether those functions became the first operative or final decision on a matter California reserves to licensed professionals.

Written reservation versus demonstrated veto#

A written reservation is probative but not conclusive because contracts describe rights, while conduct shows whether rights are usable. The most valuable evidence is a demonstrated veto: an authenticated episode in which management proposed or preferred one professional outcome, the authorized CFMG physician body chose another, and the CFMG decision controlled implementation. Repeated examples would materially strengthen the lawful-PC account.

The converse is equally probative. If professional approval is routinely sought only after staffing, policy, or discipline has already been implemented, the formal reservation may have less practical significance. If a management executive can effectively remove a physician from service for competence reasons without prior professional review, that would raise a different concern than an HR termination based on a purely nonclinical business reason.

This is why timing matters. “Approved by the physician board” is not enough without the date of approval and the date the action became operative. A board that ratifies an already implemented decision occupies a different role from a board whose approval is a condition precedent.

California law makes the categories concrete#

The Medical Board of California's corporate-practice guidance identifies decisions such as selection and hiring of physicians based on competence, setting clinical policies, and other professional matters as functions that cannot simply be transferred to lay control. The MSA's reservation clauses appear designed with that boundary in mind. The legal question is therefore not whether Wellpath can be deeply involved in operations—it plainly can under the agreement—but whether the actual allocation of authority remains consistent with the professional reservation.

A defense-oriented account would emphasize the contract language, physician officers, and any evidence of real CFMG approvals. An enforcement-oriented account would seek the first-decision chronology, delegation records, and conflict episodes. Neither should rely on branding.

Evidentiary target list#

The highest-value records are policy approval logs; physician hiring and termination matrices; credentialing and peer-review charters; minutes showing professional deliberation; staffing decisions where cost and clinical judgment diverged; and communications documenting an override or refusal. Those records would transform the MSA from an abstract legal instrument into a testable operating constitution.

The present record supports a strong but bounded conclusion: the MSA expressly reserves major professional functions to CFMG. Whether those reservations were consistently honored in practice remains an empirical question that should be answered with decision-specific evidence rather than inference from the breadth of the management platform.

X. The first-decision principle#

For every professional matter discussed in later articles, the investigation should identify the first decision that became operative. That moment often carries more evidentiary weight than later ratification. If a policy, staffing change, credentialing restriction, or physician-specific action was implemented before the authorized CFMG body acted, later approval may prove acceptance but not necessarily original control. If CFMG approval was required and obtained before implementation, the same chronology strengthens the reservation-of-authority account.

The proof package should therefore include timestamps: recommendation, professional review, decision, communication, implementation, and any appeal or ratification. This is particularly important where HR, operations, quality, and professional governance all touched the same matter. A single email saying “approved” cannot be interpreted correctly without knowing what had already happened.

The first-decision principle is neutral. It can confirm genuine physician control just as readily as it can expose an administrative override. Its value is that it turns a broad corporate-practice debate into a sequence of provable events.

The reservation analysis should include negative controls#

A useful test is to identify decisions that plainly belong to management and decisions that plainly belong to professional judgment, then examine the disputed middle. Payroll processing, benefits administration, and routine IT support are strong management-side controls. Diagnosis, treatment choice, and patient-specific prescribing are strong professional-side controls. Staffing based on professional competence, clinical-policy approval, peer review, and physician discipline may require more careful allocation.

Using negative controls prevents the analysis from treating every shared process as evidence of unlawful control. It also makes genuine boundary crossings easier to recognize. If the same nonprofessional actor who properly administers payroll is also shown to make the final competence-based physician decision, the significance comes from the change in function, not from the actor's ordinary administrative role.

Conclusion#

Article 011 should be published only at the level of confidence the record supports. The controlling proposition is the one stated in the question presented above; adjacent issues such as ownership, employer status, professional authority, bankruptcy treatment, and branding should remain separate unless a primary source supplies the bridge. The strongest contrary evidence belongs in the article, not in an editorial footnote, and any unresolved ownership, delegation, succession, or decision-chain record should remain identified as a document target rather than converted into a factual assertion.

How each source is used#

The following public authorities are tied to defined propositions in this article. They are not interchangeable: each is cited for the institutional purpose it can actually prove, and none is treated as a universal finding about ownership, employment, liability, or professional control.

• 2012 CFMG Management Services Agreement — California Forensic Medical Group, Incorporated and California Forensic Management Group, Inc., Dec. 31, 2012. Used here as operative baseline for the allocation of management functions, physician-reserved responsibilities, and the manager/professional-corporation relationship.
• Medical Board of California, Practice Information / Corporate Practice of Medicine guidance. Used here as California regulator guidance identifying physician-reserved decisions and limits on delegation of professional judgment to management organizations.
• California Business and Professions Code § 2400. Used here as the statutory anchor for California's prohibition on the unlicensed corporate practice of medicine.
• California Corporations Code § 13401.5, Moscone-Knox Professional Corporation Act. Used here as the professional-corporation ownership and licensed-person framework relevant to shareholder, director, officer, and professional-employee questions.
• California Attorney General, Apr. 1, 2026, amicus announcement defending California's corporate-practice-of-medicine prohibition in Art Center Holdings. Used here as a current California enforcement position emphasizing rights of control over professional functions, not merely formal labels.
• 2019 Assignment of Management Services Agreement, effective Jan. 1, 2019 — CFMG remained the Company while Wellpath LLC became the Manager. Used here as dated evidence of management succession without, by itself, eliminating CFMG's separate professional-corporation identity.

Sources and authorities#

1. 2012 CFMG Management Services Agreement — California Forensic Medical Group, Incorporated and California Forensic Management Group, Inc., Dec. 31, 2012 — https://www.prisonlegalnews.org/news/publications/california-forensic-medical-group-incorporated-management-services-agreement/
2. Medical Board of California, Practice Information / Corporate Practice of Medicine guidance — https://www.mbc.ca.gov/Licensing/Physicians-and-Surgeons/Practice-Information/
3. California Business and Professions Code § 2400 — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=BPC&sectionNum=2400.
4. California Corporations Code § 13401.5, Moscone-Knox Professional Corporation Act — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=CORP&sectionNum=13401.5.
5. California Attorney General, Apr. 1, 2026, amicus announcement defending California's corporate-practice-of-medicine prohibition in Art Center Holdings — https://oag.ca.gov/news/press-releases/attorney-general-bonta-files-amicus-brief-defense-california%E2%80%99s-ban-corporate
6. 2019 Assignment of Management Services Agreement, effective Jan. 1, 2019 — CFMG remained the Company while Wellpath LLC became the Manager — https://www.prisonlegalnews.org/media/publications/California\_Forensic\_Medical\_Group\_Assignment\_of\_Management\_Services\_Agreement.pdf

Citation rule: These sources support only the propositions identified in the article and source analysis. A party filing remains a party position unless adopted by a court; a corporate announcement remains a corporate representation; a contract proves allocated rights but not necessarily implementation; and a regulator's guidance or enforcement position is not an adjudication against CFMG unless a cited matter says so.